Pivotal Advance: Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin)

Journal of Leukocyte Biology

Volumn 81, Issue 1, 2007, Pages 49-58

  Rouhiainen, Ari ^a,b   Tumova, Sarka ^a   Valmu, Leena ^a   Kalkkinen, Nisse ^a   Rauvala, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Inflammation; Nitric oxide; Phosphatidylserine; RAGE; TNF

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLSERINE; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; EUKARYOTIC CELL; GENE EXPRESSION; IMMUNITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANIMALS; BACULOVIRIDAE; CELL LINE; ESCHERICHIA COLI; HMGB1 PROTEIN; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; MICE; NITRIC OXIDE; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 33845893860     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0306200     Document Type: Article

References (66)

1. Bustin, M. (2002) At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1. Sci. STKE 151, PE39.
2. Merenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., Rauvala, H. (1991) 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J. Biol. Chem. 266, 16722-16729.
3. Bianchi, M. E., Beltrame, M., Paonessa, G. (1989) Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243, 1056-1059.
4. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251.
5. Rouhiainen, A., Kuja-Panula, J., Wilkman, E., Pakkanen, J., Stenfors, J., Tuominen, R. K., Lepantalo, M., Carpen, O., Parkkinen, J., Rauvala, H. (2004) Regulation of monocyte migration by amphoterin (HMGB1). Blood 104, 1174-1182.
6. Sunden-Cullberg, J., Norrby-Teglund, A., Rouhiainen, A., Rauvala, H., Herman, G., Tracey, K. J., Lee, M. L., Andersson, J., Tokics, L., Treutiger, C. J. (2005) Persistent elevation of high-mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 33, 564-573.
7. Yamada, S., Inoue, K., Yakabe, K., Imaizumi, H., Maruyama, I. (2003) High-mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin. Chem. 49, 1535-1537.
8. Mullins, G. E., Sunden-Cullberg, J., Johansson, A. S., Rouhiainen, A., Erlandsson-Harris, H., Yang, H., Tracey, K. J., Rauvala, H., Palmblad, J., Andersson, J., et al. (2004) Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand. J. Immunol. 60, 566-573.
9. Rauvala, H., Merenmies, J., Pihlaskari, R., Korkolainen, M., Huhtala, M. L., Panula, P. (1988) The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J. Cell Biol. 107, 2293-2305.
10. Parkkinen, J., Raulo, E., Merenmies, J., Nolo, R., Kajander, E. O., Baumann, M., Rauvala, H. (1993) Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem. 268, 19726-19738.
11. Scaffidi, P., Misteli, T., Bianchi, M. E. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195.
12. Treutiger, C. J., Mullins, G. E., Johansson, A. S., Rouhiainen, A., Rauvala, H. M., Erlandsson-Harris, H., Andersson, U., Yang, H., Tracey, K. J., Andersson, J., et al. (2003) High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254, 375-385.
13. Lotze, M. T., Tracey, K. J. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342.
14. Sunden-Cullberg, J., Norrby-Teglund, A., Treutiger, C. J. (2006) The role of high mobility group box-1 protein in severe sepsis. Curr. Opin. Infect. Dis. 19, 231-236.
15. Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135-1143.
16. Hatada, T., Wada, H., Nobori, T., Okabayashi, K., Maruyama, K., Abe, Y., Uemoto, S., Yamada, S., Maruyama, I. (2005) Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb. Haemost. 94, 975-979.
17. Pachot, A., Monneret, G., Voirin, N., Leissner, P., Venet, F., Bohe, J., Payen, D., Bienvenu, J., Mougin, B., Lepape, A. (2005) Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin. Immunol. 114, 61-69.
18. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
19. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., Abraham, E. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377.
20. Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J. Y., Strassheim, D., Sohn, J. W., Yamada, S., Maruyama, I., Banerjee, A., et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290, C917-C924.
21. Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N. D., Li, J., Tracey, K. J., Demarco, R. A., Lotze, M. T., Fink, M. P., Geller, D. A., et al. (2006) High-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J. Immunol. 176, 7154-7158.
22. Salmivirta, M., Rauvala, H., Elenius, K., Jalkanen, M. (1992) Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp. Cell Res. 200, 444-451.
23. Kuniyasu, H., Yano, S., Sasaki, T., Sasahira, T., Sone, S., Ohmori, H. (2005) Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am. J. Pathol. 166, 751-760.
24. Huttunen, H. J., Fages, C., Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924.
25. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., Kasaoka, T. (2003) The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett. 550, 107-113.
26. Huttunen, H. J., Fages, C., Kuja-Panula, J., Ridley, A. J., Rauvala, H. (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 62, 4805-4811.
27. Ulloa, L., Messmer, D. (2006) High-mobility group box 1 (HMGB1) protein: Friend and foe. Cytokine Growth Factor Rev. 17, 189-201.
28. Zimmermann, K., Volkel, D., Pable, S., Lindner, T., Kramberger, F., Bahrami, S., Scheiflinger, F. (2004) Native versus recombinant high-mobility group B1 proteins: functional activity in vitro. Inflammation 28, 221-229.
29. Li, J., Wang, H., Mason, J. M., Levine, J., Yu, M., Ulloa, L., Czura, C. J., Tracey, K. J., Yang, H. (2004) Recombinant HMGB1 with cytokine-stimulating activity. J. Immunol. Methods 289, 211-223.
30. Rauvala, H., Pihlaskari, R. (1987) Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262, 16625-16635.
31. Golde, S., Chandran, S., Brown, G. C., Compston, A. (2002) Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. J. Neurochem. 82, 269-282.
32. Graziani-Bowering, G. M., Graham, J. M., Filion, L. G. (1997) A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes. J. Immunol. Methods 207, 157-168.
33. Ylonen, A., Rinne, A., Herttuainen, J., Bogwald, J., Jarvinen, M., Kalkkinen, N. (1999) Atlantic salmon (Salmo salar L.) skin contains a novel kininogen and another cysteine proteinase inhibitor. Eur. J. Biochem. 266, 1066-1072.
34. Ylonen, A., Kalkkinen, N., Saarinen, J., Bogwald, J., Helin, J. (2001) Glycosylation analysis of two cysteine proteinase inhibitors from Atlantic salmon skin: di-O-acetylated sialic acids are the major sialic acid species on N-glycans. Glycobiology 11, 523-531.
35. Chen, X., Doffek, K., Sugg, S. L., Shilyansky, J. (2004) Phosphatidylserine regulates the maturation of human dendritic cells. J. Immunol. 173, 2985-2994.
36. Froman, G., Switalski, L. M., Speziale, P., Hook, M. (1987) Isolation and characterization of a fibronectin receptor from Staphylococcus aureus. J. Biol. Chem. 262, 6564-6571.
37. T). J. Biol. Chem. 278, 3948-3956.
38. Nakano, T., Ishimoto, Y., Kishino, J., Umeda, M., Inoue, K., Nagata, K., Ohashi, K., Mizuno, K., Arita, H. (1997) Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272, 29411-29414.
39. Chou, D. K., Evans, J. E., Jungalwala, F. B. (2001) Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain. J. Neurochem. 77, 120-131.
40. Schmidt, A. M., Hasu, M., Popov, D., Zhang, J. H., Chen, J., Yan, S. D., Brett, J., Cao, R., Kuwabara, K., Costache, G., et al. (1994) Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. USA 91, 8807-8811.
41. Hou, F. F., Jiang, J. P., Guo, J. Q., Wang, G. B., Zhang, X., Stern, D. M., Schmidt, A. M., Owen, W. F., Jr. (2002) Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J. Am. Soc. Nephrol. 13, 1296-1306.
42. Valencia, J. V., Mone, M., Koehne, C., Rediske, J., Hughes, T. E. (2004) Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 47, 844-852.
43. Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis A. (2006) Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc. Diabetol. 5, 6.
44. Rouhiainen, A., Imai, S., Rauvala, H., Parkkinen, J. (2000) Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost. 84, 1087-1094.
45. Mohan, P. S., Laitinen, J., Merenmies, J., Rauvala, H., Jungalwala, F. B. (1992) Sulfoglycolipids bind to adhesive protein amphoterin (P30) in the nervous system. Biochem. Biophys. Res. Commun. 182, 689-696.
46. Raetz, C. R., Dowhan, W. (1990) Biosynthesis and function of phospholipids in Escherichia coli. J. Biol. Chem. 265, 1235-1238.
47. Savill, J., Dransfield, I., Gregory, C., Haslett, C. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975.
48. De, S. R., Ajmone-Cat, M. A., Nicolini, A., Minghetti, L. (2002) Expression of phosphatidylserine receptor and down-regulation of pro-inflammatory molecule production by its natural ligand in rat microglial cultures. J. Neuropathol. Exp. Neurol. 61, 237-244.
49. Wagner, J. P., Quill, D. M., Pettijohn, D. E. (1995) Increased DNA-bending activity and higher-affinity DNA binding of high-mobility group protein HMG-1 prepared without acids. J. Biol. Chem. 270, 7394-7398.
50. Baker, C., Isenberg, I., Goodwin, G. H., Johns, E. W. (1976) Physical studies of the nonhistone chromosomal proteins HMG-1 and HMG-2. Biochemistry 15, 1645-1649.
51. Elton, T. S., Reeves, R. (1985) The effects of oxidation on the reverse-phase high-performance liquid chromatography characteristics of the high mobility groups 1 and 2 proteins. Anal. Biochem. 149, 316-321.
52. Hardman, C. H., Broadhurst, R. W., Raine, A. R., Grasser, K. D., Thomas, J. O., Laue, E. D. (1995) Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry 34, 16596-16607.
53. Kohlstaedt, L. A., Sung, E. C., Fujishige, A., Cole, R. D. (1987) Nonhistone chromosomal protein HMG1 modulates the histone H1-induced condensation of DNA. J. Biol. Chem. 262, 524-526.
54. Gaipl, U. S., Beyer, T. D., Baumann, I., Voll, R. E., Stach, C. M., Heyder, P., Kalden, J. R., Manfredi, A., Herrmann, M. (2003) Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal-implications for antiphospholipid syndrome and systemic lupus erythematosus. Immunobiology 207, 73-81.
55. Brouckaert, G., Kalai, M., Krysko, D. V., Saelens, X., Vercammen, D., Ndlovu, M., Haegeman, G., D'Herde, K., Vandenabeele, P. (2004) Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol. Biol. Cell 15, 1089-1100.
56. Mathison, J. C., Tobias, P. S., Wolfson, E., Ulevitch, R. J. (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J. Immunol. 149, 200-206.
57. Vassallo, R., Kottom, T. J., Standing, J. E., Limper, A. H. (2001) Vitro-nectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. Am. J. Respir. Cell Mol. Biol. 25, 203-211.
58. Gao, B., Tsan, M. F. (2003) Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J. Biol. Chem. 278, 22523-22529.
59. Bausinger, H., Lipsker, D., Ziylan, U., Manie, S., Briand, J. P., Cazenave, J. P., Muller, S., Haeuw, J. F., Ravanat, C., de la Salle, H., et al. (2002) Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32, 3708-3713.
60. Gao, B., Tsan, M. F. (2003) Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. Chem. 278, 174-179.
61. Reed, R. C., Berwin, B., Baker, J. P., Nicchitta, C. V. (2003) GRP94/gp96 elicits ERK activation in murine macrophages. A role for endotoxin contamination in NF-κB activation and nitric oxide production. J. Biol. Chem. 278, 31853-31860.
62. Lowenstein, C. J., Padalko, E. (2004) iNOS (NOS2) at a glance. J. Cell Sci. 117, 2865-2867.
63. Yonekura, H., Yamamoto, Y., Sakurai, S., Watanabe, T., Yamamoto, H. (2005) Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J. Pharmacol. Sci. 97, 305-311.
64. Sumi, D., Ignarro, L. J. (2004) Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide. Diabetes 53, 1841-1850.
65. Adami, C., Bianchi, R., Pula, G., Donato, R. (2004) S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta 1742, 169-177.
66. Kim, J. B., Sig Choi, J., Yu, Y. M., Nam, K., Piao, C. S., Kim, S. W., Lee, M. H., Han, P. L., Park, J. S., Lee, J. K. (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26, 6413-6421.